YZi Labs: CEA Industries' board of directors used a poison pill plan to obstruct shareholders from exercising their right to written consent; calls on the board to avoid further manipulation.

[YZi Labs: CEA Industries Board Uses Poison Pill to Hinder Shareholders' Right to Written Consent, Urges Board to Avoid Further Manipulation] According to Mars Finance, on January 7th, YZi Labs posted on the X platform expressing disappointment with the "poison pill" strategy and articles of association amendments adopted by the company's board of directors in response to YZi Labs' written consent solicitation process. YZi Labs believes these actions aim to thwart and delay shareholders' ability to exercise their rights through written consent, with the purpose of consolidating the board's position rather than protecting shareholder interests. YZi Labs urges the board to avoid further manipulation. YZi Labs points out that the BNC board has postponed its 2025 annual meeting, originally scheduled for December 17th, and calls on the board to avoid further manipulation and ensure a fair nomination and election process for directors. Furthermore, YZi Labs refuted BNC's claim that it had never considered an alternative token strategy, stating that BNC CEO David Namdar explicitly stated at a meeting in November 2025 that he had considered switching to assets such as Solana. YZi Labs has submitted a preliminary consent statement to the SEC to expand the size of the BNC board and elect its nominated board candidates. Those involved in this solicitation include YZi Labs Management, Binance founder Changpeng Zhao, Max Baucus Sieben, David James Chapman, Marie Teresa Goody Guillené, Jiajin He, Alex Odagiu, Matthew Roszak, and Ling Zhang. Currently, YZi Labs Management directly holds 2,150,481 BNC common shares.